This content is protected against AI scraping.
A new study suggests that cannabis products may help relieve symptoms of chronic pain across several conditions, including fibromyalgia, rheumatoid arthritis, and osteoarthritis. In a 12-week clinical trial involving 164 participants in California, researchers tested three different oral cannabinoid capsules containing varying combinations of THC, CBD, and other non-intoxicating cannabinoids like CBDa, CBG, and CBC. Participants regularly reported on pain levels, mental health, sleep, cognitive function, and overall quality of life.
Overall, the study found meaningful improvements in most symptoms for people taking any of the cannabis formulations, with benefits seen in pain relief, sleep quality, mental health, and daily functioning. The different products showed largely similar effectiveness, though there were some differences—particularly in sleep improvement and reductions in neuropathic pain for one formulation. Cognitive function was the only area that did not show clear improvement.
The findings add to growing evidence that cannabis may serve as an alternative or supplement to traditional pain treatments like opioids and NSAIDs, potentially offering relief with fewer side effects. Researchers also note that non-intoxicating cannabinoids could be useful for patients who want pain relief without experiencing a “high.” The study aligns with other recent research suggesting cannabis use is associated with reduced reliance on prescription painkillers and improved quality of life for people with chronic conditions.
This is a summary.
Read the original article: Cannabis Provides ‘Significant Improvements’ In Pain For Fibromyalgia, Rheumatoid Arthritis And Osteoarthritis Patients, Study Shows
Original article written by
